Trader sentiment leans slightly toward "No" at 53.5% market-implied probability for a CDC Level 3 Travel Health Notice by December 31, driven by the absence of any such warnings despite recent Level 2 alerts for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, chikungunya outbreaks in Mayotte and elsewhere, and clade II mpox in Ghana and Liberia—all manageable with vaccinations and precautions. Key uncertainties include escalation of global poliovirus circulation across 32 countries, potential surges in U.S. measles cases (1,814 confirmed in 2026 amid 24 outbreaks), or increased H5N1 avian influenza human transmission, which remains sporadic without sustained chains. Upcoming CDC weekly surveillance reports, WHO polio emergency committee updates, and summer travel season data could tip odds if case counts or geographic spread accelerate beyond current thresholds.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트예
$116,285 거래량
$116,285 거래량
2026.12.31
예
$116,285 거래량
$116,285 거래량
2026.12.31
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader sentiment leans slightly toward "No" at 53.5% market-implied probability for a CDC Level 3 Travel Health Notice by December 31, driven by the absence of any such warnings despite recent Level 2 alerts for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, chikungunya outbreaks in Mayotte and elsewhere, and clade II mpox in Ghana and Liberia—all manageable with vaccinations and precautions. Key uncertainties include escalation of global poliovirus circulation across 32 countries, potential surges in U.S. measles cases (1,814 confirmed in 2026 amid 24 outbreaks), or increased H5N1 avian influenza human transmission, which remains sporadic without sustained chains. Upcoming CDC weekly surveillance reports, WHO polio emergency committee updates, and summer travel season data could tip odds if case counts or geographic spread accelerate beyond current thresholds.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
마켓 개설일: Jan 19, 2026, 3:15 PM ET
거래량
$116,285종료일
2026.12.31마켓 개설일
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader sentiment leans slightly toward "No" at 53.5% market-implied probability for a CDC Level 3 Travel Health Notice by December 31, driven by the absence of any such warnings despite recent Level 2 alerts for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, chikungunya outbreaks in Mayotte and elsewhere, and clade II mpox in Ghana and Liberia—all manageable with vaccinations and precautions. Key uncertainties include escalation of global poliovirus circulation across 32 countries, potential surges in U.S. measles cases (1,814 confirmed in 2026 amid 24 outbreaks), or increased H5N1 avian influenza human transmission, which remains sporadic without sustained chains. Upcoming CDC weekly surveillance reports, WHO polio emergency committee updates, and summer travel season data could tip odds if case counts or geographic spread accelerate beyond current thresholds.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
거래량
$116,285종료일
2026.12.31마켓 개설일
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader sentiment leans slightly toward "No" at 53.5% market-implied probability for a CDC Level 3 Travel Health Notice by December 31, driven by the absence of any such warnings despite recent Level 2 alerts for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, chikungunya outbreaks in Mayotte and elsewhere, and clade II mpox in Ghana and Liberia—all manageable with vaccinations and precautions. Key uncertainties include escalation of global poliovirus circulation across 32 countries, potential surges in U.S. measles cases (1,814 confirmed in 2026 amid 24 outbreaks), or increased H5N1 avian influenza human transmission, which remains sporadic without sustained chains. Upcoming CDC weekly surveillance reports, WHO polio emergency committee updates, and summer travel season data could tip odds if case counts or geographic spread accelerate beyond current thresholds.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트
외부 링크에 주의하세요.
외부 링크에 주의하세요.
자주 묻는 질문